Jack Slevin
Stock Analyst at Jefferies
(3.98)
# 1,648
Out of 4,355 analysts
39
Total ratings
50%
Success rate
23.7%
Average return
Main Sectors:
Stocks Rated by Jack Slevin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGL agilon health | Upgraded: Buy | $28 → $48 | $92.28 | -47.98% | 8 | May 7, 2026 | |
| MD Pediatrix Medical Group | Maintained: Buy | $21 → $27 | $21.54 | +25.35% | 4 | Apr 20, 2026 | |
| CVSA Covista | Maintained: Buy | $175 | $117.80 | +48.56% | 3 | Apr 2, 2026 | |
| USPH U.S. Physical Therapy | Rated: Buy | $102 | $64.26 | +58.73% | 1 | Mar 9, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $30 → $32 | $21.51 | +48.77% | 6 | Feb 26, 2026 | |
| CCRN Cross Country Healthcare | Maintained: Hold | $19 → $8.65 | $13.09 | -33.92% | 3 | Dec 4, 2025 | |
| ASTH Astrana Health | Maintained: Buy | $44 → $37 | $37.62 | -1.65% | 8 | Nov 25, 2025 | |
| AMN AMN Healthcare Services | Maintained: Hold | $22 → $21 | $28.97 | -27.51% | 4 | Aug 13, 2025 | |
| TOI The Oncology Institute | Maintained: Buy | $2.5 → $2 | $4.69 | n/a | 2 | Jun 10, 2024 |
agilon health
May 7, 2026
Upgraded: Buy
Price Target: $28 → $48
Current: $92.28
Upside: -47.98%
Pediatrix Medical Group
Apr 20, 2026
Maintained: Buy
Price Target: $21 → $27
Current: $21.54
Upside: +25.35%
Covista
Apr 2, 2026
Maintained: Buy
Price Target: $175
Current: $117.80
Upside: +48.56%
U.S. Physical Therapy
Mar 9, 2026
Rated: Buy
Price Target: $102
Current: $64.26
Upside: +58.73%
Privia Health Group
Feb 26, 2026
Reiterated: Buy
Price Target: $30 → $32
Current: $21.51
Upside: +48.77%
Cross Country Healthcare
Dec 4, 2025
Maintained: Hold
Price Target: $19 → $8.65
Current: $13.09
Upside: -33.92%
Astrana Health
Nov 25, 2025
Maintained: Buy
Price Target: $44 → $37
Current: $37.62
Upside: -1.65%
AMN Healthcare Services
Aug 13, 2025
Maintained: Hold
Price Target: $22 → $21
Current: $28.97
Upside: -27.51%
The Oncology Institute
Jun 10, 2024
Maintained: Buy
Price Target: $2.5 → $2
Current: $4.69
Upside: n/a